MAZE
Maze Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +30.0% ·
aandelenstroom +30.0% ·
netto nieuwe posities +20.0%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 64 | +2 | 15.19M | $452.36M | +8 | −6 |
| Q1 2026 | 65 | +7 | 14.90M | $445.37M | +11 | −4 |
| Q4 2025 | 57 | +5 | 12.83M | $531.64M | +5 | — |
| Q3 2025 | 12 | +3 | 5.31M | $137.60M | +3 | — |
| Q2 2025 | 7 | 0 | 2.01M | $24.69M | +1 | −1 |
| Q1 2025 | 4 | +4 | 316.77K | $3.49M | +4 | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 1.33M | +218.1% | $34.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 1.33M | +218.1% | $34.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 1.33M | +218.1% | $34.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 1.32M | +114.1% | $34.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 1.32M | +114.1% | $34.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 1.32M | +114.1% | $34.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 1.32M | +114.1% | $34.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 1.32M | +114.1% | $34.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 1.32M | +114.1% | $34.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Marshall Wace ✦ | 777.70K | +3868.5% | $20.17M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 777.70K | +3868.5% | $20.17M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 777.70K | +3868.5% | $20.17M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 655.61K | +18.2% | $17.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 655.61K | +18.2% | $17.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passief) | 473.55K | +104.8% | $12.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passief) | 473.55K | +104.8% | $12.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (passief) | 384.70K | +165.9% | $9.98M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 212.76K | — | $5.52M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 212.76K | — | $5.52M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 212.76K | — | $5.52M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 212.76K | — | $5.52M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 212.76K | — | $5.52M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 212.76K | — | $5.52M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 212.76K | — | $5.52M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 86.10K | Nieuw | $2.23M | 0.0% | New | 1 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 27.61K | +0.5% | $716,057 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 27.61K | +0.5% | $716,057 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 27.61K | +0.5% | $716,057 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 27.61K | +0.5% | $716,057 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 27.61K | +0.5% | $716,057 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 15.78K | — | $409,176 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 15.78K | — | $409,176 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 15.78K | — | $409,176 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 15.78K | — | $409,176 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 15.78K | — | $409,176 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 15.78K | — | $409,176 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Two Sigma Investments ✦ | 11.15K | Nieuw | $289,120 | 0.0% | New | 1 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 10.47K | Nieuw | $272,000 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $2.23M | 0.0% |
| Two Sigma Investments | $289,120 | 0.0% |
| T. Rowe Price | $272,000 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 164 houders, 51.62M aandelen, $1.52B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 16.14K aand · $445,621
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie